PHA-40138 - MPharm (5-year Integrated) Stage 4
Coordinator: Katie Maddock Room: HORBM1.14 Tel: +44 1782 7 34789
Lecture Time: See Timetable...
Level: Level 7
Credits: 120
Study Hours: 1200
School Office:

Programme/Approved Electives for 2022/23


Available as a Free Standing Elective






Barred Combinations


Description for 2022/23

This module aims to further develop students' core skills in relation to the practice and science of pharmacy in the context of clinical care of patients. The module completes the implementation of the plan to create a modern, integrated and fully contextualised MPharm course, continuing a course structure that will be familiar to students progressing from previous years. The structure, of one year-long fully integrated programme of study, allows material to be delivered in a coherent and logical order, and enables effective monitoring and feedback mechanisms. Students
will also have the opportunity to begin to gain the necessary theoretical background to becoming an independent pharmacist prescriber. Students will also explore specialisms within pharmacy, including research and sector-specific practice. On completion of this module students will be fully prepared to enter their final year of studies.

To further develop students core skills in relation to the practice and science of pharmacy in the context of clinical care of patients. Students will also explore specialisms within pharmacy, including research and sector-specific practice. On completion of this module students will be prepared to enter their final year of study.

Talis Aspire Reading List
Any reading lists will be provided by the start of the course.

Intended Learning Outcomes

Apply a systematic understanding of pharmacology, pharmacokinetics and pharmaceutics to the process of therapeutic decision making and the rationale and role of drug therapy: 2,3,4,5
Demonstrate knowledge of and apply an integrated approach towards patient care which links pharmaceutical science and pharmacy practice: 2,3,4,5
Apply the principles of evidence based medicine to clinical and therapeutic scenarios and critically evaluate complex therapeutic regimens: 2,3,4,5
Apply a systematic knowledge of the current understanding of the epidemiology, aetiology, pathophysiology, clinical features and diagnosis of disease states to solve problems concerning the management of specified diseases and clinical conditions: 2,3,4,5
Apply comprehensive knowledge of pharmaceutical sciences, clinical therapeutics and evidence based principles to the process of diagnosis, clinical management of disease and therapeutic decision making: 2,3,4,5
Critically evaluate patients' responses to therapeutic interventions and modify treatment where appropriate: 2,3,4,5
Apply a systematic understanding of the consultation process including an understanding of compliance and concordance and demonstrate the ability to communicate effectively with patients, carers and other healthcare professionals: 2,3,4,5
Explain in detail how molecular genetics can be applied in clinical research, in the diagnosis of disease states, and in the design of appropriate therapies using pharmacogenomics: 2,3,4,5
Apply a systematic and detailed understanding of the dynamic nature of genes in populations and the possible causes of inherited and acquired genetic diseases: 2,3,4,5
Interpret the impact of recent advances in therapeutics on patient care: 2,3,4,5
Critically evaluate current research and advanced scholarship and practice in selected specialist topics and accurately undertake data acquisition in a relevant project area if appropriate: 2,3,4,5
Communicate progress reports and conclusions on work carried out to specialist and non-specialist audiences: 2,3,4,5
Show self-direction and originality in tackling and solving problems: 2,3,4,5
Communicate complex concepts effectively, both orally and in writing, in a manner that reflects professional practice: 2,3,4,5
Demonstrate satisfactory progress with the GPhC's pre-registration performance standards: 2,3,4,5

Study hours

Taught sessions (including large- and small-group teaching sessions, seminars, tutorials, electives, projects and one-to-one interaction): 200 hours
Directed and non-directed independent study, preparation for assessments: 240 hours
N.B. there will be variation in the "contact time" for individual students based upon the balance of project and optional study topics selected.
Placements: 760 hours to run in 2 x 12 week blocks (assuming a 40 hour working week) including 5 weeks of annual leave taken at times agreed with the School of Pharmacy.

School Rules

Successful completion of MPharm Programme Stage 3 (FHEQ Level 6)
Success in Selection Activities as required by placement providers

Description of Module Assessment

1: Presentation weighted 15%
Shared Decision Making (SDM) Consultation and Patient Case
Each student to conduct a role-played consultation with a patient to arrive at a shared decision about their care They will also undertake a number of formative clinical cases followed by a summative case. These involve complex patient case studies designed to closely reflect the staged diagnosis and decision-making encountered by healthcare professionals in practice. N.B. As these are "live" teaching sessions it is not possible to assess these anonymously.

2: Coursework weighted 40%
Electives - project
Students undertaking a research project, audit or service evaluation will complete a report on this. Students will be assessed by form of a project in an area of research, audit or service evaluation chosen by tutor and student (70% of this component) followed by a poster presentation (20% of this component). The low stakes assessments (LSAs) will make up the remaining 10% of this component. There will be five small engagement tasks of equal weighting (2%); one of these being the project activity journal.

3: Exam weighted 40%
MCQs and clinical problem solving
This examination will comprise a combination of MCQ and a time-limited series of unseen cases. The exam will focus on the non-elective teaching materials studied.

4: Presentation weighted 5%
Placement case presentations
Students will be required to present to their peers a series of short case presentations based upon their experiences during the two Professional Placements. N.B. It is not possible to assess participation in this activity anonymously.

5: Professional Development weighted 0%
Professional skills development
Professional Placement Portfolio of Evidence This assessment comprises the students' achievement of competencies as aligned with the General Pharmaceutical Council's pre-registration performance standards. These will be assessed at the end of each of the two Professional Placements. Professional skills development This assessment comprises students participation in a number of activities that reflect attributes of pharmacists in professional practice. These will include participation in hospital placement activities and calculations. Final competency based assessment Students will complete a multi-station competency based assessment (CBA) that will focus on skills and knowledge required for day one of pharmacy practice. CBA stations will include for example: dispensing exercises, clinical skills, communication skills in the context of health promotion, recent changes to governance and regulatory requirements. There will be an opportunity for formative / mock assessment in the CBA under exam conditions and students will be able to gain exemption from the final assessment based on performance in the mock assessment. NB some elements of the CBA will involve face-to-face interaction and hence not be marked anonymously.